Cold case: COVID-19-triggered type 1 cryoglobulinemia
A 42-year-old male was referred to the internal medicine department because of renal failure and persistent malaise after a recent SARS-CoV-2 infection. Blood results showed anemia and severe renal insufficiency (hemoglobin of 10.3 g/dL and a creatinine of 2.19 mg/dL). Additional tests revealed a type I cryoglobulinemia with a cryoprecipitate composed of dual IgM (kappa and lambda). Further investigations on the cryoprecipitate revealed that the immunoglobulins were directed against SARS-CoV-2 antigens. In the meanwhile, our patient noticed improvement of his symptoms accompanied by resolution of laboratory abnormalities. Three months later, the cryoglobulin could no longer be detected.Type 1 cryoglobulinemia is usually associated with lymphoproliferative disorders and is characterized by various symptoms caused by cryoprecipitates occluding small blood vessels. This is, to our knowledge, the first case of type I cryoglobulinemia with proven precipitation of SARS-CoV-19 antibodies. COVID-19 induced cryoglobulinemia appears to have a mild disease course and to be self-limiting upon viral clearance.
Authors
- Rob Fijnheer (ORCID: https://orcid.org/0000-0002-7844-4774)
- Maarten F. Corsten (ORCID: https://orcid.org/0000-0003-1326-4446)
- Luuk A J van Gils
- A. H. L. Mulder
- J.C. Regelink
- Renate J. Bosma
- Carin A. Koelman
Institutions
- Meander Medisch Centrum (NL)
Publication Details
- Journal
- Annals of Hematology
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1007/s00277-024-05970-y
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78